Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab
- Status
- WITHDRAWN
- Phase
- PHASE2
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
- Status
- RECRUITING
- Phase
- NA
Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL
- Status
- COMPLETED
- Phase
- PHASE1
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Status
- COMPLETED
- Phase
- NA
CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients
- Status
- UNKNOWN
- Phase
- PHASE2
ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate
- Status
- COMPLETED
- Phase
- N/A
Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Status
- RECRUITING
- Phase
- NA
Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A